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This report describes recent disease trends in sexually transmitted diseases 
(STDs), viral hepatitis and HIV/AIDS in Massachusetts.  Detailed STD, viral 
hepatitis, and HIV/AIDS data by city and town can be accessed on the Internet at 
www.mass.gov/dph/cdc/std or http://www.mass.gov/dph/cdc/aids/.
In addition to overall trends in STDs, HIV/AIDS and viral hepatitis, this summary 
provides a description of their impact on special populations: adolescents and 
young adults, women, and men who have sex with men (MSM). Certain
racial/ethnic health disparities have also been highlighted. 
This report is intended to be a user-friendly and easy-to-read reference for health 
care providers, local health departments and community-based organizations.  
Its goal is to enhance understanding of the public health importance of STDs, 
HIV/AIDS and viral hepatitis in Massachusetts.  MDPH contact information and 
website resources are available on page 22.
Additionally, page 20 includes a description of the strengths and limitations of the 
surveillance data, as well as notes on how to interpret STD, HIV/AIDS and viral 
hepatitis data.
Unless otherwise noted, all incidence calculations represent crude rates.  The 
source for all denominator data is the U.S. Census, 2000.  All data reported are 
current as of December 1, 2007.  All information on STD cases reflect year of 
report.  Due to reporting delays related to the transition from code-base to name-
based reporting of HIV cases, all HIV/AIDS data reflect HIV diagnosed through 
2005.
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The overall number of reported chlamydia
   infections in Massachusetts in 2006 was
   15,252.  Chlamydia infection is widely   
   distributed in Massachusetts.
Chlamydia case and incidence data by city
   and town are available online at
   www.mass.gov/dph/cdc/std.
The total number of reported chlamydia
   infection cases in Massachusetts has
   more than doubled in the past ten years
   from 7,151 in 1997 to 15,276 in 2006.
Of the total reported cases in 2006, 4,191
   were among men and 11,061 were among
   women.  The greater number of chlamydia
   cases among women is partly attributable
   to a higher level of screening in women as
   compared to men.
In 2006, the incidence of chlamydia infection
   in Massachusetts among adolescents
   (ages 15-19) and young adults (ages 20-
   24) exceeded 1,000 per 100,000.  This
   contrasts with the overall Massachusetts
   chlamydia infection rate of 240.2 per
   100,000.  (Ages 15-19: 1,174 per 100,000;
   Ages 20-24: 1,228 per 100,000)
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INFERTILITY PREVENTION PROJECT
Historically, communities of color have been
   disproportionately affected by STDs.  In
   2006, compared to whites, the incidence
   of reported chlamydia infections in
   Massachusetts was 18.1 times higher in  
   blacks and 13.2 times higher in Hispanics.
Since 1997, the Division of STD Prevention has
participated in a Centers for Disease Control (CDC)-
funded Infertility Prevention Project.  The goal of this
project is to reduce infertility and other health
consequences of chlamydia infection through
increased screening and treatment of women who are
at high-risk for infection.
In 2006, as part of the Infertility Prevention Project,
22,756 specimens were tested for chlamydia
infection.  Tests results from participating sites have
yielded the following:
Site Type
(number tested)
Females
PERCENT POSITIVE FOR
CHLAMYDIA
TRACHOMATIS
School Based Health Centers
(n = 838)
5.9% 10.2%
County Jails
(n = 3195)
6.4% 7.2%
Family Planning Clinics
(n = 9101)
4.4% 14.6%
STD Clinics
(n = 8775)
7.3% 9.3%
Department of Youth Services
(n = 1339)
6.7% 2.8%
Males
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The overall number of reported cases of
   gonorrhea in Massachusetts in 2006 was
   2,428 cases.  Although gonorrhea is widely
   distributed in Massachusetts, cases are
   concentrated in urban locations.
Gonorrhea case and incidence data by city
   and town are available online at
   www.mass.gov/dph/cdc/std.
Massachusetts experienced an increase in
   reported gonorrhea cases from
   1997-2002, followed by a decline from 
   2003-2006.  Of the 2,428 total cases in 
   2006, 1,212 were in women and 1,216 
   were in men.
The incidence of gonorrhea in
   Massachusetts is highest among young
   adults (ages 20-24), followed by
   adolescents (ages 15-19).  Compared to
   the state-wide incidence (38.2 per
   100,000) of gonorrhea, the incidence was
   3.2 times higher for adolescents and 3.9
   times higher for young adults.
Page 5
GO
NO
RR
HE
A
EMERGING TRENDS IN ANTIBIOTIC RESISTANT GONORRHEA
In 2006, compared to whites, the reported
   gonorrhea incidence in Massachusetts 
   was 26.3 times higher in blacks and 10.4 
   times higher in Hispanics.
The disparity in gonorrhea incidence in
   Massachusetts reflects that at a national 
   level, where the incidence is 18 times 
   higher in blacks, and 2 times higher
   in Hispanics, when compared to whites.
   (Source:  CDC. Sexually Transmitted
   Disease Surveillance, 2005.  Atlanta, GA:
   U.S. Department of Health and Human
   Services, November 2006.)
Quinolone-resistant Neisseria gonorrhoeae (QRNG) is a strain of
bacteria that causes gonorrhea and may not be cured by
standard oral antibiotic therapies.  QRNG often requires more
aggressive approaches to diagnosis and treatment.
Results from the QRNG Prevalence Monitoring Project at the 
MDPH State Laboratory Institute indicate that the prevalence of 
QRNG continues to rise in Massachusetts.  The proportion of 
QRNG among positive gonorrhea cultures increased from 13.5% 
in 2003 to 32.5% in 2006.  Ninety-seven percent of QRNG cases 
were identified among men, and 84% of the men who tested
positive for QRNG self-identified as men who have sex with men 
(MSM).
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In 2006, there were 218 reported infectious
   primary, secondary and early latent
   syphilis cases in Massachusetts.  Although
   infectious syphilis cases have been
   reported in almost all counties, the
   majority of cases were reported in Suffolk
   County.
Infectious syphilis case and incidence data
   by city and town are available online at
   www.mass.gov/dph/cdc/std.
In Massachusetts, the male-to-female ratio
   of infectious syphilis cases changed from
   1.2 to 1 in 1997, to 9.9 to 1 in 2006.  This
   shift reflects an increase in the number of
   infectious syphilis cases diagnosed in men
   who have sex with men.  This trend has
   also been observed in other regions of the
   United States.
In contrast to chlamydia infection and
   gonorrhea, which tend to occur more
   frequently among adolescent and young
   adults, infectious syphilis is more
   commonly reported in people over age
   twenty-five years.
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SYPHILIS IN MEN WHO HAVE SEX WITH MEN (MSM)
In 2006, compared to whites, the reported
   infectious syphilis incidence in
   Massachusetts was 4.4 times higher in   
   blacks and 3.8 times higher in Hispanics.
In Massachusetts, MSM represent a higher-risk group for
infectious syphilis.  Of the 218 reported infectious syphilis
cases in 2006, 156 (72%) were in MSM.  Forty-seven
percent (74/156) of the MSM with infectious syphilis
disclosed that they were co-infected with HIV.  The majority 
(51%, 80/156) of the infectious syphilis cases in MSM were 
reported in Suffolk county.
Transmission of syphilis can occur between men through
unprotected oral and anal sex.  Additional information and 
resources regarding MSM and STDs is available online at 
www.gettestedboston.org.
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Of the 351 cities and towns in
   Massachusetts, 135 (38.5%) had at least 
   one reported newly diagnosed HIV
   infection in 2005.  The majority of newly 
   identified HIV infections were reported in
   large urban areas.
2005 HIV case and incidence data by city
   and town are available online at
   www.mass.gov/dph/cdc/aids.  Additional
   information is available through the MDPH
   HIV/AIDS Epidemiologic Profile at the
   same weblink.
In 2005 there were 884 reported, newly
   diagnosed, HIV infections and 300 deaths
   among people with HIV/AIDS in
   Massachusetts.
The number of people known to be living
   with HIV/AIDS in Massachusetts has
   increased from 12,325 in 1999 to 16,217
   in 2005.  This trend is attributable to both 
   the introduction of highly active
   antiretroviral therapy (that helps people
   live longer) and a general leveling off of
   newly diagnosed HIV infections.
In Massachusetts, in 2005, the prevalence
   rate of people living with HIV/AIDS was 
   highest among blacks and Hispanics.  As
   compared to whites, the rate of people
   living with HIV/AIDS was 11.3 times higher
   among blacks and 9.9 times higher among
   Hispanics.
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In 2005, of the 884 newly diagnosed HIV
   infections in Massachusetts, 653 (74%)
   were in men and 231 (26%) were in
   women.  Most of newly diagnosed HIV
   infections in men were in white men, and 
   the majority of newly diagnosed HIV
   infections in women were in black women.
In 2005, the primary exposure modes
   reported among newly diagnosed HIV
   cases in Massachusetts were male with
   male sex (37%), presumed heterosexual 
   sex (22%), and heterosexual sex (10%).
Since the mid-1990’s Massachusetts has
   experienced a dramatic reduction in
   mother-to-child transmission of HIV
   infection, with no HIV-infected newborns
   identified in 2005, thus far.  This success is
   attributed to improvements in HIV
   screening during pregnancy and the
   treatment of HIV-infected women with
   antiretroviral therapy.
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Overall there were 3,293 confirmed cases of 
   diagnosed hepatitis C infection reported in
   Massachusetts in 2006.  The highest
   concentrations of cases were in the urban
   areas of Boston, Worcester, and
   Springfield.
In 2006, the highest incidence rate of acute
   hepatitis B among males was in the 30-39
   year-old age group, and in females, in the
   40-49 year-old age group.
Of the total acute cases reported, 86%
   occurred in persons between ages of
   20 and 49 years.
In 2006, 36 cases of confirmed acute
   hepatitis B infection were reported in
   Massachusetts.  There was a 67%
   decrease in the number of acute hepatitis
   B cases reported from 2005 to 2006.  This
   is the lowest number of cases reported
   since 2000.  A peak of reported cases was
   observed in 2003, with 204 cases.  The 
   increase and subsequent decline in cases 
   may have been the result of enhanced 
   surveillance followed by a more restrictive 
   case definition established by CDC.
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There was a 6% decrease in the number of
   reported, diagnosed, hepatitis C infection
   cases reported in 2006 compared with 
   2005. This is the lowest number of cases
   reported in a year since 2001.
In 2006, the highest diagnosis incidence rate of
   reported hepatitis C among males was in
   the 50-59 year-old age group.  In females,
   the 40-49 and 50-59 year-old age groups
   had the highest reported incidence rates.
Of all acute hepatitis C cases reported, 58%
   occurred in persons between the ages of
   40 and 59 years.
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STDs IN ADOLESCENTS AND YOUNG ADULTS
In 2006, 69% of reported chlamydia infection
   cases, and 52% of reported gonorrhea
   cases, were in adolescents and young
   adults (ages 15-24).
In 2005, reported, newly diagnosed HIV
   infections among adolescents and young
   adults in Massachusetts had the following
   racial/ethnic distribution: black (55%),
   white (20%), Hispanic (22%), and other
   (3%).
Compared to older adults, sexually active adolescents
and young adults are at higher risk for acquiring STDs.
This higher risk is due to a combination of behavioral,
biological and cultural factors.  The higher prevalence of
STDs among adolescents also reflects multiple barriers to
quality STD prevention services, including lack of insurance
or other ability to pay, lack of transportation, discomfort with
facilities and services designed for adults, and concerns
about confidentiality.  (Source: CDC.  Sexually Transmitted
Disease Surveillance, 2005.  Atlanta, GA: U.S. Department
of Health and Human Services, November 2006.)
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In 2005, in Massachusetts, the primary
   modes of exposure for reported newly
   diagnosed HIV infection cases in
   adolescents and young adults were
   male with male sex (48%), presumed
   heterosexual (30%), heterosexual (9%),
   and injecting drug use (5%).
There has been a trend of increased HCV
   infection being reported in youth ages 15
   to 25 years.  From 2002 to 2006, the
   percent of total reported hepatitis C
   cases in 15-25 year-olds rose from 7% to
   12%.  Surveillance activities for this age
   group have been enhanced to address this
   trend.  Early data indicate that the increase
   in cases may be due to increased injection
   drug use, particularly heroin.
SEXUAL BEHAVIORS AMONG MASSACHUSETTS
HIGH SCHOOL STUDENTS BY GENDER, 2005
Source: Youth Behavioral Risk Factor Survey: www.doe.mass.edu/cnp/hprograms/yrbs/
Affirmative Responses (Percent)
Respondents: All Students
FemalesMales
Respondents: Students having sexual 
intercourse in past three months
Respondents: Students ever having
sexual intercourse
Lifetime sexual intercourse
Sexual intercourse before age 13
Four or more lifetime sexual partners
Recent sexual intercourse
Condom use at last sexual intercourse
Substance use at last sexual intercourse
Ever been or gotten someone pregnant
Ever been diagnosed with HIV or STD
47.9
8.1
14.5
32.7
71.6
26.2
8.2
6.3
42.9
2.2
10.5
35.4
59.2
20.2
10.4
6.7
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STDs AND WOMEN
Compared to gonorrhea, reported chlamydia
   infection in Massachusetts is more
   common in women and has been
   increasing in the past ten years, in part
   due to increased adoption of
   recommended routine screening by 
   healthcare providers.
While gonorrhea cases are almost equally
   distributed between women and men,
   women are over-represented among
   chlamydia cases by a ratio of 3 to 1.
The greater number of chlamydia cases in
   women is attributable to increased 
   screening in women as compared to men.
Complications of STDs are greater and more frequent
among women than men due to two primary factors.  First,
biologically, woman are more likely than men to become
infected if exposed to an STD.  Second, STDs are more
likely to remain undetected in women, resulting in delayed
diagnosis and treatment, and ultimately more untreated
infections leading to complications.  (Source:  The Hidden
Epidemic, Institute of Medicine, National Academy Press,
Washington, D.C., 1997)
Untreated STDs in women can lead to serious health
consequences, including pelvic inflammatory disease,
infertility, ectopic pregnancy, and cervical cancer.
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In 2005, the exposure modes for the 231
   newly diagnosed HIV cases reported in
   women in Massachusetts was attributed
   to presumed heterosexual sex (43%),
   heterosexual sex (26%), no identified risk
   (17%), injecting drug use (13%), and
   pediatric exposure (1%).
In 2005, 47% of women reported with
    diagnosed HIV infection were born
   outside of the U.S.  For men diagnosed in
   2005, only 23% were born outside of the 
   U.S.
Eighty-three percent of women diagnosed
   with HIV infection, who were born outside
   of the U.S., were born in regions of the
   world where heterosexual sex is the
   predominant mode of transmission of HIV
   infection.
The CDC recommends re-testing women approximately
3 months after treatment for chlamydia infection (Source:
CDC, Sexually Transmitted Diseases Treatment Guidelines.  
MMWR 55(RR-11), 2006).  Findings from eight Massachusetts 
family planning clinics indicate that 25% of women who are
treated for chlamydia infection are found to be re-infected with
chlamydia when they are tested three to eleven months
later.  These findings suggest that many women are
being re-infected by their untreated male partners.
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RACIAL / ETHNIC DISPARITIES IN STD RATES
In 2005, the racial/ethnic distribution of
   reported, newly diagnosed, HIV infections 
   in Massachusetts was as follows: white
   (38%), black (33%), Hispanic (26%), and 
   other/unknown (3%).
Although communities of color represent
   only 18% of the Massachusetts
   population, these communities bear a
   disproportionate burden of STDs.  In 2006,
   39% of the reported infectious syphilis
   cases, 68% of the reported gonorrhea
   cases, and 66% of the reported chlamydia
   infection cases occurred in individuals
   from communities of color.
Ethnic minorities have traditionally had higher rates of
reported STDs, which likely reflects limited access to
quality health care, poverty, and higher prevalence of
disease in these populations (Source:  CDC.  Trends in
Reportable Sexually Transmitted Diseases in the United 
States, 2005).  Available at
http://www.cdc.gov/std/stats/trends2005.htm.
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In Massachusetts, black and Hispanic
   women bear a higher burden of HIV
   infection compared to women of other
   races/ethnicities.
In Massachusetts, white men bear a higher
   burden of HIV infection as compared to
   men of other races/ethnicities.
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STDs IN MEN WHO HAVE SEX WITH MEN
In 2006, there were 156 infectious syphilis
   cases in men who have sex with men
   (MSM) reported in Massachusetts, of
   which 80 (51%) were in Suffolk County.
In the past six years, men who have sex
   with men accounted for the majority of
   infectious syphilis cases in Massachusetts,
   ranging from 50% in 2001 to 72% in 2006.
In 2006, the racial/ethnic breakdown of
   reported infectious syphilis cases in 
   MSM was white (71%), black (9%), 
   Hispanic (13%), other (2%), and unknown 
   (6%).  The median age of the cases was 
   41 years.
Data from several U.S. cities suggest that an
increasing number of men who have sex with men
(MSM) are acquiring STDs.  Data also suggest that an
increasing number of MSM are engaging in sexual
behaviors that place them at risk for STDs and HIV
infection.  Because STDs and the behaviors associated
with them increase the likelihood of acquiring and
transmitting HIV infection, the rise in STDs among MSM
may be associated with an increase in HIV incidence
among MSM.  (Source:  CDC.  Sexually Transmitted Disease
Surveillance, 2005.  Atlanta, GA: U.S. Department of Health
and Human Services, November 2006.)
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In 2006, 46% of the reported infectious 
   syphilis cases in MSM occurred in HIV-
   positive individuals.
Results from the Quinolone Resistant
   Neisseria Gonorrhea (QRNG) Prevalence
   Project indicate a rise in quinolone-
   resistant gonorrhea in MSM in
   Massachusetts.  The Project reported 2
   QRNG cases in 2001 and 52 QRNG cases
   in 2006.
Among males, the proportion of reported
   HIV infection cases with male to male sex
   as the reported mode of exposure
   increased from 41% in 1999 to 51% in
   2005.  The number of newly diagnosed HIV
   cases in MSM increased from 311 in 2004
   to 330 in 2005.
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HIV/AIDS Case Data STD Case Data Viral Hepatitis Case Data
Description • Collected by 
MDPH Bureau of 
Communicable Disease 
Control, HIV/AIDS 
Surveillance Program. 
• Reportable statewide.
• All licensed healthcare 
providers and 
laboratories are required 
by law to report. 
• Cases of AIDS and HIV 
infection are currently 
reported by name, but 
HIV cases included in 
this report were reported 
by a code extracted 
from identifiers from 
1999 through 2006.
• Collected by 
MDPH Bureau of 
Communicable Disease 
Control, Division of STD 
Prevention. 
• Reportable statewide.
• All laboratories and 
healthcare providers are 
required by law to report 
nine STDs, including 
syphilis, gonorrhea, 
chlamydia infection, and 
lymphoma granuloma 
venereum. 
• Collected by 
MDPH Bureau of 
Communicable Disease 
Control, Office of 
Integrated Surveillance 
and Informatics 
Services.
• Reportable statewide.
• All laboratories and 
healthcare providers 
are required to report 
laboratory indicators 
of hepatitis B and C 
infection.
Strengths • Statewide reporting, 
population-based.
• Risk information is 
available. 
• Completeness of 
reporting is high.
• Comparable with other 
states.
• Statewide reporting, 
population-based.
• Comparable with other 
states.
• Enhanced reporting 
of positive laboratory 
results.
• Statewide reporting, 
population-based.
• Enhanced reporting of 
acute cases, hepatitis B 
cases in child-bearing 
aged women and 
children and hepatitis 
C cases among youth 
ages 15-25.
Limitations • Under-reporting 
(10%-15%) hampers 
interpretation of AIDS 
case data.
• Not all AIDS cases 
are reported at time of 
diagnosis (reporting 
lag).
• HIV data may be 
incomplete because 
some HIV-infected 
people may not have 
been tested or have 
entered care.
• Under-reporting of up to 
10% of STD cases.
• Race/ethnicity is 
missing in 31% of 
gonorrhea cases and 
37% of chlamydia 
infection cases.
• Reports are not 
received on those 
not seeking care or 
screening.
• Bias is introduced for 
some STDs, such as 
chlamydia infection, 
where screening of 
asymptomatic persons 
occurs more frequently 
in women than in men.
• Race data are missing 
in 56% of confirmed 
acute hepatitis B and 
80% of confirmed 
hepatitis C cases; 
ethnicity data are 
missing in 58% of acute 
hepatitis B and 75% of 
confirmed hepatitis C 
cases.
• Risk history data is 
missing in a majority of 
reported hepatitis B and 
C cases.
• Reports not received on 
those not seeking care.
Summary of Strengths and Limitations of Data
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Interpreting STD, HIV/AIDS and Viral Hepatitis Data
I.  HIV/AIDS Exposure Mode Definitions
The HIV/AIDS exposure mode indicates the most probable risk behavior associated with HIV
infection.  Assignment of exposure mode is done in accordance with Centers for Disease Control and
Prevention guidelines when multiple exposure modes are reported.  Following is a description of the
exposure mode categories:
•    MSM (Male to Male Sex):  Includes men who report sexual contact with other men, and men
 who report sexual contact with both men and women.
•    IDU (Injection Drug use):  Cases in persons who report injection drug use.
•    MSM/IDU:  Cases in men who report both injection drug use and sexual contact with other men.
•    Heterosexual Sex:  Cases in persons who report specific heterosexual sex with a person with,
or at increased risk for, HIV infection (e.g. an injection drug user).  The sub-categories for this
mode of transmission are listed below.
•    Heterosexual Sex w/ an Injection Drug User
•    Heterosexual Sex w/ a person w/ HIV infection or AIDS
•    Heterosexual Sex w/ Bisexual male
 •    Other Heterosexual Sex:  Includes all other sub-categories of risk, such as heterosexual
contact with a person infected through a blood transfusion.
•    Presumed Heterosexual:  Cases in persons who report heterosexual sex but do not report
    any other personal risk nor any knowledge of specific risk in their sex partners.  Presumed
    Heterosexual is an exposure mode category used by the Massachusetts HIV/AIDS Surveillance
   Program.  The Centers for Disease Control and Prevention (CDC) categorizes these cases as
   No Identified Risk.
•    Pediatric:  Infection before the age of 13 years, including mother to child transmission through
    pregnancy, childbirth or breastfeeding and blood transfusions to children.
•    NIR (No Identified Risk):  Cases in persons with no reported history of exposure to HIV through
    any of the listed exposure categories.  Follow-up is conducted to determine risk for those cases
    that are initially reported without a risk identified.
II.  Race/Ethnicity of STD and HIV/AIDS Cases
Race/ethnicity references to whites and blacks represent persons who are white non-Hispanics and
black non-Hispanics, respectively.  All references to Hispanic for race/ethnicity represent persons of
Hispanic heritage regardless of race.
III.  References to Newly Diagnosed HIV Infections
Newly diagnosed HIV infections/cases include all persons diagnosed with HIV in 2005, including
those who were concurrently or subsequently diagnosed with AIDS.
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STD, HIV/AIDS and Viral Hepatitis Contact Information
Division of STD Prevention, HIV/AIDS Surveillance,
and Ratelle STD/HIV Prevention Training Center
Topic Contact E-Mail Phone
Policy Development and 
Administration
Thomas Bertrand (Division Director) Thomas.Bertrand@state.ma.us 617-983-6941
Sylvie Ratelle STD/HIV 
Prevention Training Center
Katherine Hsu (Medical Director)
Janine Dyer (Coordinator)
Katherine.Hsu@state.ma.us
Janine.Dyer@state.ma.us
617-983-6948
617-983-6964
STD/HIV/AIDS
Surveillance and 
Epidemiology
Jim Murphy (Director)
Yuren Tang (Epidemiologist)
James.Murphy2@dph.state.ma.us
Yuren.Tang@state.ma.us
617-983-6577
617-983-6554
STD Clinical Services Bill Dumas (Clinical) Bill.Dumas@state.ma.us 617-983-6950
STD Disease Intervention 
Field Services and 
STD Partner Notification
Hillary Johnson
(Director of Field Services)
Hillary.Johnson@state.ma.us
 
617-983-6951
STD Health Education, 
Training, and Prevention
Sheila Nelson 
David Goudreau
Sheila.Nelson@state.ma.us
David.Goudreau@state.ma.us
617-983-6961
617-983-6835
Topic Contact E-Mail Phone
Policy, Planning, Resource 
Allocation, Research, and 
Evaluation
Kevin Cranston (Bureau Director)
Deborah Isenberg 
(Director of Research and Evaluation)
Thera Meehan 
(Director of Policy and Planning)
Tammy Goodhue (Director of Training
and Health Communication)
Kevin.Cranston@state.ma.us
Deborah.Isenberg@state.ma.us
Thera.Meehan@state.ma.us
Tammy.Goodhue@state.ma.us
617-624-5303
617-624-5311
617-624-5328
617-624-5338
Administration and Finance, 
Personnel, Contracts and 
Procurement, Budget
Bob Carr (Deputy Bureau Director)
Ceci Dunn (Director of Operations)
Bob.Carr@state.ma.us
Ceci.Dunn@state.ma.us
617-624-5317
617-624-5370
Consumer Office Sophie Lewis 
(Director of Consumer Office)
Paul Goulet 
(Consumer Office Coordinator) 
Sophie.Lewis@state.ma.us
Paul.b.Goulet@state.ma.us
617-624-5366
617-624-5389
Prevention and Education Barry Callis 
(Director of AIDS Prevention and  
Education)
Barry.Callis@state.ma.us 617-624-5316
HIV Clinical Care, Home-
Based HIV Care, HIV 
Counseling and Testing, 
Corrections-Based HIV 
Services
Brenda Cole 
(Director of Health Services)
Brenda.L.Cole@state.ma.us 617-624-5333
HIV Client Services,Case 
Management, Peer Support
Services, Housing Support
Services, Service 
Coordination Collaboratives
Linda Goldman
(Director of Client Services)
Linda.Goldman@state.ma.us 617-624-5347
Topic Contact E-Mail Phone
Viral Hepatitis Program Daniel Church (Hepatitis C Coordinator)
Clare O’Donoghue (Contract Manager)
Daniel.Church@state.ma.us
Clare.O’Donoghue@state.ma.us
617-983-6800
617-983-6866
Hepatitis Surveillance and 
Epidemiology
Franny Elson (Epidemiologist)
Shauna Onofrey (Epidemiologist)
Franny.Elson@state.ma.us
Shauna.Onofrey@state.ma.us
617-983-4382
617-983-6776
HIV/AIDS Bureau
Viral Hepatitis Program
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STD, HIV/AIDS and Viral Hepatitis Resources
Division of STD Prevention, HIV/AIDS Surveillance,
and Ratelle STD/HIV Prevention Training Center
Type of Training Contact Information and Website
STD Education, STD Partner Notification, and 
STD Reporting 
617-983-6940
www.mass.gov/dph/cdc/std
HIV/AIDS Reporting and Surveillance Projects 617-983-6560
www.mass.gov/dph/cdc/aids
HIV/AIDS Provider Trainings 508-752-7313
www.mass.gov/Eeohhs2/docs/dph/aids/prov_training_calendar.pdf
Viral Hepatitis Education 617-983-6800
http://www.mass.gov/dph/cdc/epii/imm/imm.htm
STD/HIV Diagnosis, Treatment, and Management 617-983-9645
www.mass.gov/dph/cdc/stdtcmai/courses.htm
Material Contact Information and Website
STD, HIV, Viral Hepatitis Fact Sheets 617-983-6940 or 617-624-5338
www.mass.gov/dph/cdc/factsheets/factsheets.htm
HIV/AIDS Reporting for Health Care Providers 
Brochure
617-983-6560
www.mass.gov/dph/cdc/aids/hiv_report_for_health_care_providers.htm
Viral Hepatitis Posters and Brochures 617-983-6800
www.mass.gov/dph/cdc/epii/hepatitis/hepa.htm or
www.mass.gov/hepc
STD/HIV Diagnosis, Treatment, and 
Management Toolkits
617-983-9645
www.mass.gov/dph/cdc/stdtcmai/stdtcmai.htm
MDPH and Bureau Funded Websites
Division of STD Prevention   www.mass.gov/dph/cdc/std
HIV/AIDS Bureau    www.mass.gov/dph/aids
HIV/AIDS Surveillance   www.mass.gov/dph/cdc/aids
Viral Hepatitis Program   
Hepatitis C    www.mass.gov/hepc
Hepatitis A    www.mass.gov/dph/cdc/epii/hepatitis/hepa/htm
Sylvie Ratelle STD/HIV Prevention Training Center www.mass.gov/dph/cdc/stdtcmai/stdtcmai.htm
GetTestedBoston (for MSM)   www.gettestedboston.org
URhealthstyle (for Urban Teens)  www.URhealthstyle.com
National Websites
Center for Disease Control and Prevention www.cdc.gov
Division of STD Prevention  www.cdc.gov/std
Division of HIV/AIDS Prevention  www.cdc.gov/hiv
Division of Viral Hepatitis  www.cdc.gov/ncidod/diseases/hepatitis
National Network of STD/HIV Prevention 
Training Centers    www.stdhivpreventiontraining.org
Training
     Professional training to community based organizations, local public health departments, and medical
     providers can be requested and is free of charge.
Material and Clinical Toolkits
     Health education materials and clinical toolkits can be requested free of charge.

